Company Overview
Snapshot
Founded in January 2010 by Tzameret Fuerst, Circ MedTech operates with 1–10 employees. The company developed the PrePex device, a non-surgical male circumcision solution, which received expanded use approval from the WHO for adolescents in May 2016.
Business overview
Circ MedTech developed the PrePex device, a non-surgical solution for adult male circumcision designed to be safe, simple, scalable, and cost-effective. This technology is integrated into comprehensive HIV prevention programs. The PrePex procedure is noted for its minimal invasiveness and quick application, enabling trained nurses to conduct procedures in various clean settings. The company operates within the Health Tech & Life Sciences sector, focusing on medical devices and medical treatment, serving markets in India, the United States, Africa, and Indonesia.
Strategic signal
In November 2017, news highlighted the significant impact of Circ MedTech's PrePex device in curbing HIV transmission through mass non-surgical circumcision programs in Rwanda. This demonstrates the device's proven efficacy and scalability in public health initiatives, signaling its potential for widespread adoption in global health strategies aimed at disease prevention.
Company Intelligence Q&A
- What is Circ MedTech's primary product?
- Circ MedTech's primary product is the PrePex device, a non-surgical solution for adult male circumcision.
- When was Circ MedTech founded and by whom?
- Circ MedTech was founded in January 2010 by Tzameret Fuerst.
- What significant recognition did the PrePex device receive in 2015?
- In November 2015, the PrePex device won a top tech award for its non-invasive circumcision technology.
- How has the World Health Organization (WHO) endorsed the PrePex device?
- In May 2016, the WHO expanded the use of the PrePex device to adolescents, recognizing its utility in public health programs.
- In which regions does Circ MedTech primarily operate or target?
- Circ MedTech targets geomarkets including India, the United States, Africa, and Indonesia.